Bio-Rad Laboratories Inc.

Last updated September 27, 2026

Organization details

Legal name
Bio-Rad Laboratories Inc.
Ownership
Public
Status
Active
Sector (GICS)
Information Technology
SIC code
3826 — Laboratory Analytical Instruments
Jurisdiction of incorporation
Delaware
Headquarters city
Hercules
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BIO
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000012208
EIN
94-1381833
Wikidata ID
Q2904022

Board of directors

Chief executives

Norman D. Schwartz · Chairman, President, and CEO
Dates unknown

Board connections

3 of this board's directors also sit on 4 other boards. 1 is in the same sector.

Network of Bio-Rad Laboratories Inc.'s board connections Kyntra Bio Inc. Kyntra Bio Inc. Lifecore Biomedical Inc. Lifecore Biomedical In... Rapid Micro Biosystems Inc. Rapid Micro Biosystems... SI-BONE Inc. SI-BONE Inc. Gregory K. Hinckley Gregory K. Hinckley Jeffrey L. Edwards Jeffrey L. Edwards Melinda Litherland Pei Melinda Litherland P... Bio-Rad Laboratories Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$135,597
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Oct 24, 2026 DiVincenzo Jonathan P. Officer (President & COO) Option exercise +1,869 — —
Oct 24, 2026 DiVincenzo Jonathan P. Officer (President & COO) Shares withheld for tax −951 $369.95 $351,822
Oct 20, 2026 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise +1,044 — —
Oct 20, 2026 EVRAN SEDAT Officer (EVP, Global Supply Chain) Shares withheld for tax −487 $354.50 $172,642
Sep 6, 2026 Schwartz Allison Director Option exercise +92 — —
Sep 6, 2026 BARRY JAMES Officer (EVP, President, LSG) Option exercise +1,056 — —
Sep 6, 2026 Norman D. Schwartz Director, Officer (Chairman & CEO), 10% owner Option exercise +3,455 — —
Sep 6, 2026 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise +1,536 — —
Sep 6, 2026 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise +864 — —
Sep 6, 2026 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise +768 — —
Sep 6, 2026 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise +1,152 — —
Sep 6, 2026 Schwartz Allison Director Shares withheld for tax −34 $386.11 $13,128
Sep 6, 2026 BARRY JAMES Officer (EVP, President, LSG) Shares withheld for tax −470 $386.11 $181,472
Sep 6, 2026 Norman D. Schwartz Director, Officer (Chairman & CEO), 10% owner Shares withheld for tax −1,854 $386.11 $715,848
Sep 6, 2026 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Shares withheld for tax −782 $386.11 $301,938

Organizations in the same sector, closest in location and size first.

Questions about Bio-Rad Laboratories Inc.

Who is the CEO of Bio-Rad Laboratories Inc.?

Norman D. Schwartz is Bio-Rad Laboratories Inc.'s Chairman, President, and CEO.

How many directors are on Bio-Rad Laboratories Inc.'s board?

Bio-Rad Laboratories Inc.'s board has 6 directors: Arnold A. Pinkston, Gregory K. Hinckley, Jeffrey L. Edwards, Melinda Litherland Pei, Norman D. Schwartz and Schwartz Allison.

Are Bio-Rad Laboratories Inc. insiders buying or selling shares?

Over the last 12 months, Bio-Rad Laboratories Inc. insiders made no open-market purchases and sold $135,597 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="bio-rad-laboratories-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.